Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May 29:9:28.
doi: 10.1186/1471-244X-9-28.

A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder

Marcelo Feijó Mello  1 , Mary Sau Ling Yeh, Jair Barbosa Neto, Luciana Lorens Braga, Jose Paulo Fiks, Daniela Deise Mendes, Tais S Moriyama, Nina Leão Marques Valente, Mariana Caddrobi Pupo Costa, Patricia Mattos, Rodrigo Affonseca Bressan, Sergio Baxter Andreoli, Jair Jesus Mari
Affiliations
Randomized Controlled Trial

A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder

Marcelo Feijó Mello et al. BMC Psychiatry. .

Abstract

Background: Topiramate might be effective in the treatment of posttraumatic stress disorder (PTSD) because of its antikindling effect and its action in both inhibitory and excitatory neurotransmitters. Open-label studies and few controlled trials have suggested that this anticonvulsant may have therapeutic potential in PTSD. This 12-week randomized, double-blind, placebo-controlled clinical trial will compare the efficacy of topiramate with placebo and study the tolerability of topiramate in the treatment of PTSD.

Methods and design: Seventy-two adult outpatients with DSM-IV-diagnosed PTSD will be recruited from the violence program of Federal University of São Paulo Hospital (UNIFESP). After informed consent, screening, and a one week period of wash out, subjects will be randomized to either placebo or topiramate for 12 weeks. The primary efficacy endpoint will be the change in the Clinician-administered PTSD scale (CAPS) total score from baseline to the final visit at 12 weeks.

Discussion: The development of treatments for PTSD is challenging due to the complexity of the symptoms and psychiatric comorbidities. The selective serotonin reuptake inhibitors (SSRIs) are the mainstream treatment for PTSD, but many patients do not have a satisfactory response to antidepressants. Although there are limited clinical studies available to assess the efficacy of topiramate for PTSD, the findings of prior trials suggest this anticonvulsant may be promising in the management of these patients.

Trial registration: NCT 00725920.

Trial registration: ClinicalTrials.gov NCT00725920.

PubMed Disclaimer

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Fourth. Washington DC: APA; 1994.
    1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–60. - PubMed
    1. Bisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD) Cochrane Database of Systematic Reviews. 2007. p. CD003388. - PubMed
    1. Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional metaanalysis of psychotherapy for PTSD. American Journal of Psychiatry. 2005;162:214–227. doi: 10.1176/appi.ajp.162.2.214. - DOI - PubMed
    1. NICE Post-traumatic stress disorder (PTSD) Clinical Guideline 26. National Institute for Clinical Excellence London; 2005. The management of PTSD in adults and children in primary and secondary care.

Publication types

MeSH terms

Associated data